Updates

CSRxP ANALYSIS: PHARMACEUTICAL INDUSTRY’S PROFIT MARGINS STILL 10 TIMES GREATER THAN OTHER SECTORS OF DRUG SUPPLY CHAIN

Jan 13, 2026

New Report Underscores How Brand Name Drug Companies Ride High on Egregious… Read More

DOSE OF REALITY: DRUG MAKERS INCREASINGLY UTILIZING DEVICE PATENTS TO EXTEND EXCLUSIVITY ON BLOCKBUSTER DRUGS

Jan 9, 2026

New Research Shows Drugmakers Increasingly Rely on Patents Disconnected from… Read More

DOSE OF REALITY: NEW REPORT PROJECTS MORE THAN 50 PERCENT DROP IN OUT-OF-POCKET COSTS FOR TOP MEDICARE DRUGS IN 2026

Jan 6, 2026

AARP Analysis Highlights Substantial Cost Savings for Nearly Nine Million… Read More

CSRxP STATEMENT ON THE PASSING OF DAVID MITCHELL

Jan 5, 2026

Founder and President of Patients for Affordable Drugs Was a Tireless and… Read More

CSRxP: BIG PHARMA RINGS IN 2026 WITH MORE THAN 300 PRICE INCREASES ON BRAND NAME DRUGS, OUTPACING START OF 2025

Jan 5, 2026

Big Pharma Giants Including Pfizer and GSK Kickoff a New Year with Price Hikes… Read More

Dose Of Reality: Breaking Down Big Pharma’s Year of Bad Behavior in 2025: Part IV: Big Pharma’s Debunked Innovation Rhetoric

Dec 31, 2025

Big Pharma Undercut Its Own False Claims About Innovation in 2025 With each… Read More

Dose Of Reality: Breaking Down Big Pharma’s Year of Bad Behavior in 2025: Part II: Big Pharma’s DTC Advertising

Dec 29, 2025

Big Pharma’s Aggressive Marketing Directly Targeting Consumers to Boost… Read More

Dose of Reality: Breaking Down Big Pharma’s Year of Bad Behavior in 2025: Part I: Big Pharma’s Egregious Pricing Practices

Dec 29, 2025

Take a Look Back on Big Pharma’s Year of Price Hikes and Increasingly… Read More

THEY SAID IT! U.S. REPRESENTATIVE DAVE TAYLOR CALLS FOR LIST PRICE TRANSPARENCY IN BIG PHARMA’S DIRECT-TO-CONSUMER ADVERTISING

Dec 17, 2025

Lawmaker Highlights Broad-Based Support for Bipartisan Solution to Disclose… Read More

THEY SAID IT! BIPARTISAN GROUP OF LAWMAKERS URGE ADMINISTRATION TO SUPPORT CRACKDOWN ON BIG PHARMA’S PATENT THICKETS

Dec 16, 2025

Members of Congress Say Addressing “Patent Thickets Surrounding Branded… Read More